GLAXOSMITHKLINE (GSK) has announced it anticipates an intermittent stock outs for Twinrix Adult (combined hepatitis A and B vaccine) this month.
Twinrix Junior (combined hepatitis A and hepatitis B vaccine) continues to be available, the company said, while hepatitis B supplies for Government programs is not impacted.
In addition, GSK said there was an on-going supply constraint of Engerix-B Adult dose (hepatitis B surface antigen recombinant vaccine) in Australia.
Production is now back to normal but it will take time to re-build capacity to backfill supply.
Engerix-B Paediatric is still available, GSK confirmed.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Jul 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Jul 17